Skip to main content

Table 6 Cerebrovascular complications

From: Analysis of cardiovascular mortality, bleeding, vascular and cerebrovascular events in patients with atrial fibrillation vs. sinus rhythm undergoing transfemoral Transcatheter Aortic Valve Implantation (TAVR)

Follow-upStroke Total population (n = 257) SR-group(n = 148) AF-group(n = 109) p Value OR (95% CI)
30 days 3.1% (8/257) 2.7% (4/148) 3.7% (4/109) 0.726 1.37 (0.34–5.61)
3 months 3.1% (8/257) 2.7% (4/148) 3.7% (4/109) 0.726 1.37 (0.34–5.61)
6 months 3.3% (8/241) 2.9% (4/137) 3.8% (4/104) 0.728 1.34 (0.33–5.49)
12 months 5.0% (11*/219) 4.0% (5/124) 6.3% (6/95) 0.537 1.62 (0.48–5.47)
  1. Lists the cerebrovascular complications up to the one-year follow-up. The strokes are shown for the entire patient population and for the two groups during the follow-up period. The parentheses list the number of strokes and the number of patients available for analysis. * Ten ischemic strokes and one hemorrhagic stroke. The occurrence of stroke in the two groups showed no significant difference